E. Riudor

925 total citations
33 papers, 496 citations indexed

About

E. Riudor is a scholar working on Molecular Biology, Clinical Biochemistry and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, E. Riudor has authored 33 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 21 papers in Clinical Biochemistry and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in E. Riudor's work include Metabolism and Genetic Disorders (21 papers), Biochemical and Molecular Research (15 papers) and Mitochondrial Function and Pathology (6 papers). E. Riudor is often cited by papers focused on Metabolism and Genetic Disorders (21 papers), Biochemical and Molecular Research (15 papers) and Mitochondrial Function and Pathology (6 papers). E. Riudor collaborates with scholars based in Spain, United States and Netherlands. E. Riudor's co-authors include Antònia Ribes, José Antonio Arranz, A Ballabriga, Vicente Rubio, P. Briones, Clara Marco‐Marín, Juan Córdoba, C. Domínguez, Paz Briones and Neus Potau and has published in prestigious journals such as PEDIATRICS, Annals of Neurology and Journal of Hepatology.

In The Last Decade

E. Riudor

31 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Riudor Spain 15 316 279 73 72 71 33 496
José Antonio Arranz Spain 13 206 0.7× 208 0.7× 112 1.5× 108 1.5× 38 0.5× 29 578
Hiroki Terazono Japan 7 428 1.4× 255 0.9× 17 0.2× 51 0.7× 65 0.9× 8 498
Sabine Illsinger Germany 14 230 0.7× 227 0.8× 10 0.1× 44 0.6× 122 1.7× 32 491
A. Green United Kingdom 11 305 1.0× 179 0.6× 11 0.2× 20 0.3× 107 1.5× 28 415
Mary Anne Preece United Kingdom 11 166 0.5× 162 0.6× 9 0.1× 24 0.3× 75 1.1× 20 377
Robin Williams Australia 6 183 0.6× 158 0.6× 9 0.1× 28 0.4× 136 1.9× 10 537
Alice Mazur United States 11 270 0.9× 164 0.6× 6 0.1× 55 0.8× 143 2.0× 13 570
Takeyori Saheki Japan 7 267 0.8× 119 0.4× 7 0.1× 40 0.6× 63 0.9× 16 334
Bianca T. van Maldegem Netherlands 8 223 0.7× 191 0.7× 11 0.2× 28 0.4× 106 1.5× 13 339
Lisa Sniderman King United States 7 191 0.6× 90 0.3× 12 0.2× 18 0.3× 75 1.1× 12 263

Countries citing papers authored by E. Riudor

Since Specialization
Citations

This map shows the geographic impact of E. Riudor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Riudor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Riudor more than expected).

Fields of papers citing papers by E. Riudor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Riudor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Riudor. The network helps show where E. Riudor may publish in the future.

Co-authorship network of co-authors of E. Riudor

This figure shows the co-authorship network connecting the top 25 collaborators of E. Riudor. A scholar is included among the top collaborators of E. Riudor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Riudor. E. Riudor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Narbona, Juan, Leslie Matalonga, Mireia del Toro, et al.. (2015). A leaky splicing mutation in NFU1 is associated with a particular biochemical phenotype. Consequences for the diagnosis. Mitochondrion. 26. 72–80. 15 indexed citations
2.
Ventura‐Cots, Meritxell, José Antonio Arranz, Macarena Simón‐Talero, et al.. (2013). Safety of Ornithine Phenylacetate in Cirrhotic Decompensated Patients. Journal of Clinical Gastroenterology. 47(10). 881–887. 54 indexed citations
3.
Font, Aida, Aleix Navarro‐Sastre, Leslie Matalonga, et al.. (2012). Protein expression profiles in patients carrying NFU1 mutations. Contribution to the pathophysiology of the disease. Journal of Inherited Metabolic Disease. 36(5). 841–847. 27 indexed citations
4.
Soler‐Palacín, Pere, Andrea Martín‐Nalda, Xavier Martínez‐Gómez, et al.. (2011). Hyperlactatemia and in Utero Exposure to Antiretrovirals: Is the Control Group the Clue?. AIDS Research and Human Retroviruses. 28(8). 752–758. 5 indexed citations
5.
Oria, Marc, Jordi Romero‐Giménez, José Antonio Arranz, et al.. (2011). Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis. Journal of Hepatology. 56(1). 109–114. 20 indexed citations
6.
Clemente, María, José Antonio Arranz, E. Riudor, et al.. (2010). Glycogen Storage Disease Type III with Hypoketosis. Journal of Pediatric Endocrinology and Metabolism. 23(8). 833–6. 2 indexed citations
7.
Rodríguez, Carlos E., José Antonio Arranz, Núria Colomé, et al.. (2009). Proteomic analysis in cerebrospinal fluid of patients with atypical nonketotic hyperglycinemia and pulmonary hypertension – A pilot study. PROTEOMICS - CLINICAL APPLICATIONS. 3(12). 1430–1439. 3 indexed citations
8.
Arranz, José Antonio, E. Riudor, Clara Marco‐Marín, & Vicente Rubio. (2007). Estimation of the total number of disease‐causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential. Journal of Inherited Metabolic Disease. 30(2). 217–226. 37 indexed citations
9.
Toro, Mireia del, José Antonio Arranz, Alfons Macaya, et al.. (2006). Progressive vacuolating glycine leukoencephalopathy with pulmonary hypertension. Annals of Neurology. 60(1). 148–152. 16 indexed citations
10.
Rigante, Donato, et al.. (2005). Gene symbol: FAH. Disease: tyrosinaemia 1.. PubMed. 118(3-4). 537–537.
11.
Arranz, José Antonio, et al.. (2003). Reflexiones preliminares sobre una\n\naplicación científico-médica de actualidad: la clonación. Redalyc (Universidad Autónoma del Estado de México). 1 indexed citations
12.
Riudor, E., et al.. (2003). Partial Ornithine Transcarbamylase Deficiency. PEDIATRICS. 111(5). 1123–1124. 1 indexed citations
13.
Martı́nez, G, Antònia Ribes, P. Briones, et al.. (1998). Medium‐chain acyl‐CoA dehydrogenase deficiency in Spain. Journal of Inherited Metabolic Disease. 21(6). 693–694.
14.
Riudor, E.. (1998). Commentary: Neonatal onset in fatty acid oxidation disorders: How can we minimize morbidity and mortality?. Journal of Inherited Metabolic Disease. 21(6). 619–623. 4 indexed citations
15.
Ribes, Antònia, E. Riudor, Barbara Garavaglia, et al.. (1998). Mild or absent clinical signs in twin sisters with short-chain acyl-CoA dehydrogenase deficiency. European Journal of Pediatrics. 157(4). 317–320. 30 indexed citations
16.
Riudor, E., José Antonio Arranz, Manuel G. Roig, et al.. (1998). Neonatal medium‐chain acyl‐CoA dehydrogenase deficiency presenting with very high creatine kinase levels. Journal of Inherited Metabolic Disease. 21(6). 673–674. 2 indexed citations
17.
Riudor, E., Celia Pérez‐Cerdá, José Antonio Arranz, et al.. (1995). Metabolic coma with ketoacidosis and hyperglycaemia in 2‐methylacetoacetyl‐CoA thiolase deficiency. Journal of Inherited Metabolic Disease. 18(6). 748–749. 11 indexed citations
18.
Ribes, Antònia, et al.. (1993). Pearson syndrome: Altered tricarboxylic acid and urea‐cycle metabolites, adrenal insufficiency and corneal opacities. Journal of Inherited Metabolic Disease. 16(3). 537–540. 32 indexed citations
19.
Riudor, E., et al.. (1991). Liver transplantation in two children with tyrosinaemia type I: Biochemical aspects. Journal of Inherited Metabolic Disease. 14(3). 281–284. 4 indexed citations
20.
Ribes, Antònia, et al.. (1987). Pyroglutamic acid as a marker of increased orotic acid. Journal of Inherited Metabolic Disease. 10(S2). 311–313. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Antonio Arranz Breakdown of academic impact, for papers by Hiroki Terazono Breakdown of academic impact, for papers by Sabine Illsinger Breakdown of academic impact, for papers by A. Green Breakdown of academic impact, for papers by Mary Anne Preece Breakdown of academic impact, for papers by Robin Williams Breakdown of academic impact, for papers by Alice Mazur Breakdown of academic impact, for papers by Takeyori Saheki Breakdown of academic impact, for papers by Bianca T. van Maldegem Breakdown of academic impact, for papers by Lisa Sniderman King
Rankless by CCL
2026